Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 1 |
2024 | 2 |
2025 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
FSP1 inhibition enhances olaparib sensitivity in BRCA-proficient ovarian cancer patients via a nonferroptosis mechanism.
Cell Death Differ. 2024 Apr;31(4):497-510. doi: 10.1038/s41418-024-01263-z. Epub 2024 Feb 19.
Cell Death Differ. 2024.
PMID: 38374229
Free PMC article.
[Establishment and preliminary application of organoids in ovarian cancer].
Zhang L, Meng HY, Zhang YS, Miao HX, Yuan L, Zhou SL, Jiang Y, Wan YC, Cheng WW.
Zhang L, et al.
Zhonghua Fu Chan Ke Za Zhi. 2023 Feb 25;58(2):112-120. doi: 10.3760/cma.j.cn112141-20221103-00677.
Zhonghua Fu Chan Ke Za Zhi. 2023.
PMID: 36776006
Chinese.
Item in Clipboard
The serum LDH level and KELIM scores are potential predictors of a benefit from bevacizumab first-line therapy for patients with advanced ovarian cancer.
Liu Y, Yuan L, Lin Z, Huixian M, Huangyang M, Cheng W.
Liu Y, et al.
Clin Transl Oncol. 2024 Jun 21. doi: 10.1007/s12094-024-03569-3. Online ahead of print.
Clin Transl Oncol. 2024.
PMID: 38904923
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.